Experimental Ebola treatment in Phase 1 clinical trial
by Press Release from Outbreak News Today on (#3QWCF)
A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. The Phase 1 clinical trial is examining the safety and tolerability of a single monoclonal antibody called mAb114, which was developed by scientists at the National Institute of Allergy and Infectious ["]
The post Experimental Ebola treatment in Phase 1 clinical trial appeared first on Outbreak News Today.